1. Home
  2. RKLB vs ILMN Comparison

RKLB vs ILMN Comparison

Compare RKLB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Lab USA Inc.

RKLB

Rocket Lab USA Inc.

BUY

Current Price

$52.81

Market Cap

41.3B

Sector

Industrials

ML Signal

BUY

Logo Illumina Inc.

ILMN

Illumina Inc.

SELL

Current Price

$269.34

Market Cap

37.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RKLB
ILMN
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3B
37.0B
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
RKLB
ILMN
Price
$52.81
$269.34
Analyst Decision
Buy
Buy
Analyst Count
21
21
Target Price
$102.26
★ $241.05
AVG Volume (30 Days)
★ 16.4M
2.5M
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
2.63
★ 170.87
EPS
N/A
★ 2.22
Revenue
$601,799,000.00
★ $4,343,000,000.00
Revenue This Year
$59.29
$6.48
Revenue Next Year
$38.82
$6.46
P/E Ratio
★ N/A
$120.92
Revenue Growth
★ 37.96
N/A
52 Week Low
$37.57
$94.00
52 Week High
$150.85
$309.35

Technical Indicators

Market Signals
Indicator
RKLB
ILMN
Relative Strength Index (RSI) 33.60 54.67
Support Level N/A $254.00
Resistance Level $77.02 $309.35
Average True Range (ATR) 3.29 15.36
MACD -1.43 -2.32
Stochastic Oscillator 11.99 27.62

Price Performance

Historical Comparison
RKLB
ILMN

About RKLB Rocket Lab USA Inc.

Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, and rest of the world and earns key revenue from the United States.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: